𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interferon therapy in chronic hepatitis B reduces progression to cirrhosis and hepatocellular carcinoma: a meta-analysis

✍ Scribed by Y.-F. Yang; W. Zhao; Y.-D. Zhong; H.-M. Xia; L. Shen; N. Zhang

Book ID
108886225
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
461 KB
Volume
16
Category
Article
ISSN
1352-0504

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Does interferon therapy for chronic hepa
Does interferon therapy for chronic hepatitis B reduce the risks of developing cirrhosis and hepatocellular carcinoma?
✍ Anna S. F. Lok πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 413 KB

Objective: To estimate the cost-effectiveness of interferon-a2B for the treatment of patients with chronic hepatitis B infection who are positive for hepatitis B e antigen (HBeAg). Design: Meta-analysis of nine randomized controlled trials and cost-effectiveness analysis, projecting the clinical an

Meta-analysis: Reduced incidence of hepa
Meta-analysis: Reduced incidence of hepatocellular carcinoma in patients not responding to interferon therapy of chronic hepatitis C
✍ Yasuhiro Miyake; Yoshiaki Iwasaki; Kazuhide Yamamoto πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 252 KB πŸ‘ 1 views

## Abstract Interferon treatment for chronic hepatitis C reduces the incidence of hepatocellular carcinoma (HCC) in sustained responders. However, estimation of the effect of interferon treatment on HCC development in nonresponders is yet to be fully implemented. We conducted a meta‐analysis of 3 r